Therapeutic role of Ricinus communis L. and its bioactive compounds in disease prevention and treatment

被引:40
作者
Abdul, Waseem Mohammed [1 ]
Hajrah, Nahid H. [1 ]
Sabir, Jamal S. M. [1 ]
Al-Garni, Saleh M. [2 ]
Sabir, Meshaal J. [1 ]
Kabli, Saleh A. [2 ]
Saini, Kulvinder Singh [1 ,3 ]
Bora, Roop Singh [1 ,3 ]
机构
[1] King Abdulaziz Univ, Dept Biol Sci, Biotechnol Res Grp, Fac Sci, Jeddah 21589, Saudi Arabia
[2] King Abdulaziz Univ, Dept Biol Sci, Fac Sci, Jeddah 21589, Saudi Arabia
[3] Eternal Univ, Dept Biotechnol, Baru Sahib 173101, HP, India
关键词
Ricinus communis; Bioactive compounds; Ethnomedicine; Molecular targets; Anti-cancer; Pharmacology; ADULT EMERGENCE INHIBITION; NATURAL-PRODUCTS; LEAF EXTRACTS; CASTOR-OIL; ESCHERICHIA-COLI; RICINOLEIC ACID; FLAVONOIDS; ALPHA;
D O I
10.4103/1995-7645.228431
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Ricinus communis L. (R. communis), commonly known as castor oil plant, is used as a traditional natural remedy or folkloric herb for the control and treatment of a wide range of diseases around the globe. Various studies have revealed the presence of diverse phytochemicals such as alkaloids, flavonoids, terpenes, saponins, phenolic compounds such as kaempferol, gallic acid, ricin, rutin, lupeol, ricinoleic acid, pinene, thujone and gentisic acid. These phytochemicals have been responsible for pharmacological and therapeutic effects, including anticancer, antimicrobial, insecticidal, antioxidant, anti-diabetic, antinociceptive, anti-inflammatory, bone regenerative, analgesic, and anticonvulsant activity. R. communis harbours phytochemicals which have been shown to target peroxisome proliferator activated receptor (PPAR), nuclear factor NF- kappa -B, cytochrome p450, P38 mitogen-activated protein kinases kinase (p38 MAPK), tumor protein P53, B-cell lymphoma-extra-large (Bcl-xL) and vascular endothelial growth factor receptor-2 (VEGFR-2). Considering its wide variety of phytochemicals, its pharmacological activity and the subsequent clinical trials, R. communis could be a good candidate for discovering novel complementary drugs. Further experimental and advanced clinical studies are required to explore the pharmaceutical, beneficial therapeutic and safety prospects of R. communis with its phytochemicals as a herbal and complementary medicine for combating various diseases and disorders.
引用
收藏
页码:177 / 185
页数:9
相关论文
共 81 条
  • [21] Use of traditional medicines to cope with climate-sensitive diseases in a resource poor setting in Bangladesh
    Haque, Md Aminul
    Louis, Valerie R.
    Phalkey, Revati
    Sauerborn, Rainer
    [J]. BMC PUBLIC HEALTH, 2014, 14
  • [22] Houbairi S., 2015, Eur J Med Plants, V10, P1, DOI [10.9734/EJMP/2015/19928, DOI 10.9734/EJMP/2015/19928, DOI 10.9734/ejmp/2015/19928]
  • [23] Iqbal J, 2012, ISRN PHARM, V2012
  • [24] Isichei CO, 2000, PHYTOTHER RES, V14, P40, DOI 10.1002/(SICI)1099-1573(200002)14:1<40::AID-PTR323>3.0.CO
  • [25] 2-1
  • [26] Jeyam M., 2014, Sci Rep, V6, P24027
  • [27] Jeyaseelan E. Christy, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P717, DOI 10.1016/S2221-1691(12)60216-0
  • [28] COUMARINS AND FLAVONOIDS OF RICINUS COMMUNIS GROWING IN EGYPT
    KHAFAGY, SM
    MAHMOUD, ZF
    SALAM, NAE
    [J]. PLANTA MEDICA, 1979, 37 (02) : 191 - 191
  • [29] The evolving role of natural products in drug discovery
    Koehn, FE
    Carter, GT
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (03) : 206 - 220
  • [30] Antibiotic Resistance Modulation and Modes of Action of (-)-α-Pinene in Campylobacter jejuni
    Kovac, Jasna
    Simunovic, Katarina
    Wu, Zuowei
    Klancnik, Anja
    Bucar, Franz
    Zhang, Qijing
    Mozina, Sonja Smole
    [J]. PLOS ONE, 2015, 10 (04):